MET three-lens brief
Evidence-based stock research on MET. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
MET moved -0.19% overnight.
- RSI at 70 — technically overbought.
- Negative free cash flow last quarterly (-$12.74B).
- Debt-to-equity of 226.0 — balance-sheet-heavy.
MET closed at $80.08 (-0.19%) as of 2026-05-04. Market cap: $51.66B. P/E (trailing) 17.0. Concerns: rSI at 70 — technically overbought.; negative free cash flow last quarterly (-$12.74B).. Last quarter: Revenue $24.19B, net income $778.00M, free cash flow -$12.74B.
Why three lenses on MET, not one.
A single reasoning model has blind spots it doesn’t know about. We examine METacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MET" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MET brief"></iframe>